1. Home
  2. GRNQ vs INTS Comparison

GRNQ vs INTS Comparison

Compare GRNQ & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • INTS
  • Stock Information
  • Founded
  • GRNQ 2013
  • INTS 2012
  • Country
  • GRNQ Malaysia
  • INTS United States
  • Employees
  • GRNQ N/A
  • INTS N/A
  • Industry
  • GRNQ EDP Services
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • INTS Health Care
  • Exchange
  • GRNQ Nasdaq
  • INTS Nasdaq
  • Market Cap
  • GRNQ 10.6M
  • INTS 10.9M
  • IPO Year
  • GRNQ 2018
  • INTS 2023
  • Fundamental
  • Price
  • GRNQ $1.43
  • INTS $0.23
  • Analyst Decision
  • GRNQ
  • INTS Strong Buy
  • Analyst Count
  • GRNQ 0
  • INTS 4
  • Target Price
  • GRNQ N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • GRNQ 21.5K
  • INTS 4.0M
  • Earning Date
  • GRNQ 11-12-2025
  • INTS 11-12-2025
  • Dividend Yield
  • GRNQ N/A
  • INTS N/A
  • EPS Growth
  • GRNQ N/A
  • INTS N/A
  • EPS
  • GRNQ N/A
  • INTS N/A
  • Revenue
  • GRNQ $3,256,679.00
  • INTS N/A
  • Revenue This Year
  • GRNQ N/A
  • INTS N/A
  • Revenue Next Year
  • GRNQ N/A
  • INTS N/A
  • P/E Ratio
  • GRNQ N/A
  • INTS N/A
  • Revenue Growth
  • GRNQ N/A
  • INTS N/A
  • 52 Week Low
  • GRNQ $0.80
  • INTS $0.19
  • 52 Week High
  • GRNQ $2.50
  • INTS $4.30
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 49.03
  • INTS 32.86
  • Support Level
  • GRNQ $1.21
  • INTS $0.27
  • Resistance Level
  • GRNQ $1.50
  • INTS $0.30
  • Average True Range (ATR)
  • GRNQ 0.11
  • INTS 0.02
  • MACD
  • GRNQ 0.01
  • INTS -0.00
  • Stochastic Oscillator
  • GRNQ 57.89
  • INTS 6.39

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: